Heart failure (HF) is a prevalent yet silent epidemic, affecting 26 million people and costing global healthcare systems ...
The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...
March 12, 2021 — Since early in the pandemic, COVID-19 has been associated with heart problems, including reduced ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 12, 2021 — Philips Healthcare announced the final, five-year results of two major randomized controlled trials ...
March 12, 2021 — A new review suggests that blood vessel damage and impaired oxygen delivery related to COVID-19 play a ...
March 12, 2021 — Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Intra-cardiac Echocardiography (ICE) uses catheter-based cardiac ultrasound array to image anatomy and devices inside ...
While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these ...
March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 8, 2021 — University of Kansas Health System Cardiologist Ashley Simmons, M.D., knew there could and should be a ...
March 3, 2021 — Medtronic announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac ...
March 3, 2021 — Impulse Dynamics recently announced that DEKRA Certification B.V., a global regulatory organization ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...
March 3, 2021 — Farapulse Inc. announced the first patients were treated in the ADVENT Trial, a U.S. Food and Drug ...
March 2, 2021 — Penn State Health Milton S. Hershey Medical Center became the second hospital in the nation to implant a ...